CVS Health Corporation $CVS Shares Acquired by Atria Investments Inc

Atria Investments Inc lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 13.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,633 shares of the pharmacy operator’s stock after acquiring an additional 9,949 shares during the quarter. Atria Investments Inc’s holdings in CVS Health were worth $6,305,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of CVS. Avion Wealth increased its holdings in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares during the last quarter. Corundum Trust Company INC acquired a new position in shares of CVS Health during the third quarter worth about $29,000. Harbor Asset Planning Inc. purchased a new stake in shares of CVS Health during the 2nd quarter worth $30,000. Finally, Front Row Advisors LLC raised its holdings in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Jefferies Financial Group boosted their price objective on CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Wolfe Research upped their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Evercore upped their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Nineteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Trading Up 0.7%

CVS Health stock opened at $78.45 on Friday. The firm’s 50 day moving average price is $78.64 and its two-hundred day moving average price is $76.13. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The firm has a market cap of $99.80 billion, a price-to-earnings ratio of 56.85, a price-to-earnings-growth ratio of 0.81 and a beta of 0.50. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same period last year, the company posted $1.19 earnings per share. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.